Related Experiment Video

Updated: May 27, 2026

Ultra-Fast Amplicon-Based Next-Generation Sequencing in Non-Squamous Non-Small Cell Lung Cancer
07:59

Ultra-Fast Amplicon-Based Next-Generation Sequencing in Non-Squamous Non-Small Cell Lung Cancer

Published on: September 8, 2023

Therapeutic advances in non-small cell lung cancer

Eric Vallières1, Solange Peters, Paul Van Houtte

  • 1Department of Thoracic Surgery, Swedish Cancer Institute, Seattle, WA, USA.

Thorax
|November 8, 2011
PubMed

Insights

Recent non-small cell lung cancer (NSCLC) research shows significant therapeutic advances. Personalized medicine, improved surgical techniques, and novel therapies offer new hope for patients with lung cancer.

Area of Science:

  • Oncology
  • Thoracic Surgery
  • Radiation Oncology

Background:

  • Therapeutic progress in non-small cell lung cancer (NSCLC) has been slow, with limited improvements in early-stage surgical resection and advanced-stage chemotherapy or radiotherapy.
  • Recent breakthroughs signal a turning point in NSCLC treatment strategies.

Purpose of the Study:

  • To review recent therapeutic advances in non-small cell lung cancer (NSCLC).
  • To highlight progress in patient selection, surgical techniques, targeted therapies, radiotherapy, radiofrequency ablation, and palliative care.

Main Methods:

  • A review of recent scientific literature and clinical advancements in NSCLC treatment.
  • Expert insights from an international panel on key developments across major disciplines.

Main Results:

  • Significant improvements in patient selection and minimally invasive surgical approaches.
  • Identification of targetable mutations leading to personalized, targeted anticancer treatments.
  • Advancements in radiotherapy technology, emergence of radiofrequency ablation (RFA), and integration of palliative care.

Conclusions:

  • The past 18 months have marked an inflection point in NSCLC therapy, driven by personalized medicine and technological innovation.
  • A multidisciplinary approach integrating surgery, targeted therapy, advanced radiotherapy, and palliative care is crucial for improving patient outcomes.

More Related Videos

Detection of Targetable Alterations in Non-small Cell Lung Cancer using Next-generation Sequencing05:17

Detection of Targetable Alterations in Non-small Cell Lung Cancer using Next-generation Sequencing

Published on: October 10, 2025

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Treatment Resistent Cancers02:56

Treatment Resistent Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...